{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Isolated Hepatic Perfusion with Melphalan for Liver Metastases"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "this trial involved 19 patients"
      },
      "Participants": {
        "score": 2,
        "evidence": "Eligibility criteria included WHO performance status 0-1 and specific hematological and biochemical parameters."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Patients received a 60-min IHP with 200 mg melphalan."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study assesses the efficacy of isolated hepatic perfusion (IHP) with melphalan in patients with isolated liver metastases from diverse primary tumors."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was tumor response per RECIST criteria, evaluated over a median follow-up of 74 months."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Randomisation and blinding were not applicable as this was a single-arm study."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Randomisation and blinding were not applicable as this was a single-arm study."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "this trial involved 19 patients"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Among the 18 patients analyzed"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "33% achieved a partial hepatic response, 50% had stable disease, and 17% were immediately progressive."
      },
      "Harms": {
        "score": 1,
        "evidence": "reversible grade 3 or 4 hepatotoxicity occurred in 56%, and veno-occlusive disease in 22%."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "no trial registration or funding information was provided."
      },
      "Funding": {
        "score": 0,
        "evidence": "no trial registration or funding information was provided."
      }
    },
    "total_score": 14,
    "max_score": 25
  },
  "model": "gpt-4o"
}